Exicure, Inc. (XCUR)
NASDAQ: XCUR · Real-Time Price · USD
1.290
+0.030 (2.38%)
Sep 22, 2026, 4:00 PM EDT - Market closed
Exicure Market Cap
Exicure has a market cap or net worth of $8.44 million as of September 22, 2026. Its market cap has decreased by -65.25% in one year.
Market Cap
8.44M
Enterprise Value
6.73M
1-Year Change
-65.25%
Ranking
Category
Stock Price
$1.29
ChartMarket Cap Chart
Since May 22, 2018, Exicure's market cap has decreased from $122.30M to $8.44M, a decrease of -93.10%. That is a compound annual growth rate of -27.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 8.40M | -75.65% |
| Dec 31, 2025 | 34.50M | 16.16% |
| Dec 31, 2024 | 29.70M | 494.00% |
| Dec 29, 2023 | 5.00M | -12.28% |
| Dec 30, 2022 | 5.70M | -67.98% |
| Dec 31, 2021 | 17.80M | -88.47% |
| Dec 31, 2020 | 154.40M | -28.95% |
| Dec 31, 2019 | 217.30M | 42.03% |
| Dec 31, 2018 | 153.00M | 25.10% |
| May 22, 2018 | 122.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ensysce Biosciences | 8.91M |
| CollPlant Biotechnologies | 8.62M |
| Soligenix | 8.05M |
| Evogene | 8.03M |
| Longeveron | 7.94M |
| XTL Biopharmaceuticals | 7.87M |
| Skye Bioscience | 7.81M |
| Imunon | 7.63M |